Physician profile
Jennifer Collins
NPI 1033969126
$778.80
in general payments reported to CMS, 2019-2025
9 companies · $445 in 2025
The $445 reported for 2025 was more than what 75% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $334 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $242.12 | 2024-2025 | Embold Fibered, General - Embolics, Icefx Cryoablation System |
| Edwards Lifesciences Corporation | $201.05 | 2024-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $134.45 | 2025 | Symplicity G3 |
| E.R. Squibb & Sons, L.L.C. | $58.26 | 2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $52.68 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Regeneron Healthcare Solutions, INC. | $30.02 | 2025 | Dupixent |
| Inspire Medical Systems, INC. | $22.40 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $19.43 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.39 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.